Milvue vs Rayscape (2026)
Two European radiograph vendors covering both trauma and chest, close enough that the decision turns on delivery. Milvue returns a pre filled structured report to the reporting system within seconds across seven pathology families, with authorization in three jurisdictions and an explicit choice between secure cloud and on premise. Rayscape reads chest broadly with longitudinal comparison against prior scans, adds lung nodule work on computed tomography, and carries independent evaluation from a tuberculosis screening deployment, which is a harder test than a reader study. If the bottleneck is report turnaround, Milvue delivers a draft rather than a flag. If it is chest reading depth and change over time, Rayscape goes further.
- It returns a pre filled structured report to the reporting system in seconds across seven pathology families spanning trauma and chest.
- Authorization across three jurisdictions with clearly delineated scope, documented rather than implied.
- Deployment is an explicit choice between secure cloud and on premise, which is better disclosed than most peers manage.
- Chest coverage is broad with longitudinal comparison against a patient's prior scans, plus lung nodule work on computed tomography.
- Independent evaluation in a tuberculosis screening context is a harder test than a retrospective reader study.
- On premise and cloud are both offered, which matters where images cannot leave the institution.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Milvue and Rayscape are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Milvue | Rayscape |
|---|---|---|
| Primary category | Radiology & Imaging AI | Radiology & Imaging AI |
| Founded | 2018 | 2019 |
| Headquarters | Grenoble, France | Timisoara, Romania |
| Website | milvue.com | rayscape.ai |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Milvue its top capability grade on AI Centrality and FDA and Regulatory Status. Set against Rayscape, Milvue grades higher on FDA and Regulatory Status. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Rayscape its top capability grade on AI Centrality. Set against Milvue, Rayscape grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Milvue or Rayscape?
On the axes where the AI Health Index separates them, Milvue grades higher on FDA and Regulatory Status, and Rayscape grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Rayscape leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Milvue and Rayscape differ most?
The widest separation the AI Health Index records between Milvue and Rayscape is on FDA and Regulatory Status, where Milvue grades A and Rayscape grades C. That axis sits in the Regulatory and Compliance group, so it should carry the most weight for a buyer whose binding constraint is where regulatory exposure sits and who carries it.
Where do Milvue and Rayscape grade the same?
The AI Health Index grades Milvue and Rayscape the same on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
Both publish headline performance figures that are not comparable across vendors, since each defines findings and reference standards differently, so ask for performance on the findings your population actually presents with. Neither publishes an independent security attestation. Milvue's clearance reader study spans physicians of differing expertise, which is more subgroup information than most vendors provide, though it addresses reader variation rather than patient variation. Prevalence determines the false positive burden more than sensitivity does.